We are hiring! Click to View Open Positions.

Posters & Presentations

October 2024

World Muscle Society Annual Congress

Longer-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with nonambulatory SMA: Results from the 48-month TOPAZ study

View This Poster

October 2024

World Muscle Society Annual Congress

Apitegromab in spinal muscular atrophy: Baseline characteristics of participants enrolled in the phase 3 SAPPHIRE study

View This Poster

June 2024

American Diabetes Association Scientific Sessions

The Anti-Myostatin Antibody SRK-439 Promotes Healthy Body Composition in Combination with GLP-1RAs in a Mouse Model of Obesity

View This Presentation

June 2024

Cure SMA Annual Conference

An Update on Scholar Rock’s Progress in SMA

View This Poster

June 2024

American Society of Clinical Oncology

Phase1 study (DRAGON) of SRK-181 (linavonkibart), a latent TGFβ1inhibitor, combined with pembrolizumab in anti-PD1 resistant patients with advanced solid tumors: Updated results of expansion phase

View This Presentation

March 2024

4^th Scientific International Congress on SMA

Effect Of Apitegromab on Motor Function and Patient-reported Outcomes at 36 Months in Patients Aged 2–21 Years with Spinal Muscular Atrophy

View This Presentation